{"symbol": "MYOV", "companyName": "Myovant Sciences Ltd.", "exchange": "New York Stock Exchange", "industry": "Biotechnology", "website": "http://www.myovant.com", "description": "Myovant Sciences Ltd is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its product candidate is relugolix.", "CEO": "Lynn Seely", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}